LeMaitre Vascular (LMAT) News Today $99.06 +0.83 (+0.84%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Moderate Buy" by BrokeragesShares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, six have assJanuary 17 at 2:54 AM | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Short Interest UpdateLeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,210,000 shares, a growth of 37.5% from the December 15th total of 880,000 shares. Approximately 5.9% of the shares of the stock are sold short. Based on an average daily volume of 157,900 shares, the short-interest ratio is presently 7.7 days.January 16 at 8:58 AM | marketbeat.comLeMaitre Vascular: Losing SteamJanuary 15 at 10:35 AM | seekingalpha.comJPMorgan Chase & Co. Decreases Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)JPMorgan Chase & Co. trimmed its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 21.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 101,059 shares of the medical instruments supplier's stockJanuary 14, 2025 | marketbeat.comJane Street Group LLC Reduces Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Jane Street Group LLC trimmed its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 50.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,606 shares of the medical instrumentsDecember 28, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Barclays PLCBarclays PLC grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 394.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 36,577 shares of the medical instruments supplier's stock after purchasing an additional 29,180 sharesDecember 24, 2024 | marketbeat.comGeode Capital Management LLC Grows Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Geode Capital Management LLC grew its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 4.5% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 542,523 shares of the medical instruments supplierDecember 23, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Moderate Buy" from BrokeragesShares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have received an average rating of "Moderate Buy" from the nine ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, six have given a bDecember 23, 2024 | marketbeat.comLake Street Reaffirms Their Buy Rating on Lemaitre Vascular (LMAT)December 20, 2024 | markets.businessinsider.comState Street Corp Has $76.36 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)State Street Corp lifted its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 3.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 822,085 shares of the medical instruments supplier's stock after puDecember 18, 2024 | marketbeat.comLeMaitre Vascular Prices $150M Convertible Notes OfferingDecember 17, 2024 | markets.businessinsider.comLeMaitre Vascular (NASDAQ:LMAT) Sees Unusually-High Trading Volume - What's Next?LeMaitre Vascular (NASDAQ:LMAT) Sees Unusually-High Trading Volume - Still a Buy?December 17, 2024 | marketbeat.comLeMaitre Vascular Prices $150 Million Convertible Senior NotesDecember 17, 2024 | markets.businessinsider.comLeMaitre Vascular prices $150M convertible senior notesDecember 17, 2024 | msn.comFmr LLC Buys 8,114 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Fmr LLC boosted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 330.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,568 shares of the medical instruments supplier's stock afteDecember 17, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down - What's Next?LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down - Should You Sell?December 16, 2024 | marketbeat.comLeMaitre Vascular To Offer $150 Mln Of Senior Notes; Pre-Market Stock DownDecember 16, 2024 | markets.businessinsider.comLeMaitre Vascular to Offer $150M in Convertible NotesDecember 16, 2024 | tipranks.comLeMaitre Vascular Announces Proposed Convertible Senior Notes OfferingDecember 16, 2024 | globenewswire.comM&T Bank Corp Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)M&T Bank Corp bought a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 16,699 shares of the medical instruments supplier's stock, valued at approximDecember 15, 2024 | marketbeat.comStifel Financial Corp Purchases 7,060 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Stifel Financial Corp grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 10.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,194 shares of the medical instruments supplier'sDecember 14, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 25.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 35,267 shares of the medicaDecember 14, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Cut to "Hold" at StockNews.comStockNews.com lowered shares of LeMaitre Vascular from a "buy" rating to a "hold" rating in a report on Friday.December 13, 2024 | marketbeat.comJanus Henderson Group PLC Reduces Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Janus Henderson Group PLC decreased its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 9.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,834 shares of the medical instrumenDecember 11, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $17.79 Million Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Charles Schwab Investment Management Inc. boosted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 6.3% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 191,511 shares of the medical instruments supplier's stock after puDecember 8, 2024 | marketbeat.comBNP Paribas Financial Markets Has $2.59 Million Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT)BNP Paribas Financial Markets boosted its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 80.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,829 shares of the medical instruments supplier's sDecember 7, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Bridgewater Associates LPBridgewater Associates LP lessened its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 65.6% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,083 shares of the medical instruments supplier's stockDecember 3, 2024 | marketbeat.comTownsquare Capital LLC Has $4.45 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Townsquare Capital LLC increased its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 38.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 47,953 shares of the medical instruments supplieNovember 29, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine research firms that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, six have given a buy ratingNovember 28, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Moderate Buy" by BrokeragesLeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine brokerages that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating aNovember 28, 2024 | marketbeat.comLeMaitre to Participate at Upcoming Investor Conferences in DecemberNovember 25, 2024 | globenewswire.comShould You Be Adding LeMaitre Vascular (NASDAQ:LMAT) To Your Watchlist Today?November 25, 2024 | finance.yahoo.comVictory Capital Management Inc. Purchases 10,011 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Victory Capital Management Inc. increased its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 23.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 53,060 shares of the medical instruments supplNovember 23, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Bridget A. Ross Sells 3,750 SharesNovember 20, 2024 | insidertrades.comOppenheimer Asset Management Inc. Has $536,000 Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Oppenheimer Asset Management Inc. cut its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 53.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,771 shares of the medical instrumNovember 20, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Los Angeles Capital Management LLCLos Angeles Capital Management LLC raised its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 23.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,656 shares of the medicalNovember 13, 2024 | marketbeat.comPortside Wealth Group LLC Purchases New Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Portside Wealth Group LLC acquired a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 5,352 shares of the medical instruments supplier's stock, valued at approximately $497,00November 9, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year High - Should You Buy?LeMaitre Vascular (NASDAQ:LMAT) Hits New 52-Week High - Here's What HappenedNovember 8, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Harbor Capital Advisors Inc.Harbor Capital Advisors Inc. grew its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 113.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,093 shares of the medical instruments supplierNovember 5, 2024 | marketbeat.comFY2024 EPS Forecast for LeMaitre Vascular Boosted by AnalystLeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) - Equities researchers at Barrington Research lifted their FY2024 earnings per share (EPS) estimates for LeMaitre Vascular in a note issued to investors on Friday, November 1st. Barrington Research analyst M. Petusky now forecasts that the medicNovember 4, 2024 | marketbeat.comLeMaitre Vascular: The Market Is Catching On To This Dividend Growth StoryNovember 3, 2024 | seekingalpha.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Moderate Buy" from AnalystsLeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the nine research firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, six have given aNovember 3, 2024 | marketbeat.comLeMaitre Vascular Third Quarter 2024 Earnings: Beats ExpectationsNovember 2, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans $0.16 Quarterly DividendLeMaitre Vascular, Inc. (NASDAQ:LMAT) announced a quarterly dividend on Thursday, October 31st. Stockholders of record on Thursday, November 21st will be paid a dividend of 0.16 per share by the medical instruments supplier on Thursday, December 5th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date is Thursday, November 21st.November 2, 2024 | marketbeat.comF M Investments LLC Has $11.48 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)F M Investments LLC lifted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 36.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 123,545 shares of the medical iNovember 2, 2024 | marketbeat.comKeyBanc Remains a Hold on Lemaitre Vascular (LMAT)November 2, 2024 | markets.businessinsider.comLemaitre Vascular (LMAT) Gets a Buy from Stifel NicolausNovember 2, 2024 | markets.businessinsider.comIn-Depth Examination Of 4 Analyst Recommendations For LeMaitre VascularNovember 2, 2024 | benzinga.comLeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...November 2, 2024 | finance.yahoo.comLeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results, Beats Estimates By $0.05 EPSLeMaitre Vascular (NASDAQ:LMAT - Get Free Report) issued its quarterly earnings results on Thursday. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.05. LeMaitre Vascular had a net margin of 18.33% and a return on equity of 12.41%. The firm had revenue of $54.82 million for the quarter, compared to analyst estimates of $53.50 million. During the same period in the previous year, the business earned $0.33 EPS. The company's revenue was up 15.6% compared to the same quarter last year.November 1, 2024 | marketbeat.com Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address LMAT Media Mentions By Week LMAT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LMAT News Sentiment▼0.770.64▲Average Medical News Sentiment LMAT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LMAT Articles This Week▼54▲LMAT Articles Average Week Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GKOS News STVN News BLCO News INSP News NARI News PRCT News NVST News IRTC News NVCR News ENOV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LMAT) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
